Key result
A combined computational-experimental approach identified two putative cholesterol-binding regions in the transmembrane domain of Kir2.1, suggesting a novel cholesterol binding motif.
The identification of two putative cholesterol-binding regions in Kir2.1 provides new insights into the mechanisms underlying lipid regulation of ion channels.
Hypothesis-generating for Kir2.1 lipid regulation; extends animal-model insights but leaves clinical translation open.
Inwardly rectifying potassium (Kir) channels play an important role in setting the resting membrane potential and modulating membrane excitability. We have recently shown that cholesterol regulates representative members of the Kir family and that in the majority of the cases, cholesterol suppresses channel function. Furthermore, recent data indicate that cholesterol regulates Kir channels by specific sterol-protein interactions, yet the location of the cholesterol binding site in Kir channels is unknown. Using a combined computational-experimental approach, we show that cholesterol may bind to two nonanular hydrophobic regions in the transmembrane domain of Kir2.1 located between adjacent subunits of the channel. The location of the binding regions suggests that cholesterol modulates channel function by affecting the hinging motion at the center of the pore-lining transmembrane helix that underlies channel gating either directly or through the interface between the N and C termini of the channel. Background: Cholesterol modulates inwardly rectifying potassium (Kir) channels. Results: Using a combined computational-experimental approach, we identified two putative cholesterol-binding regions in Kir2.1 that suggest the existence of a novel cholesterol binding motif. Conclusion: Cholesterol binds to nonannular surfaces in the transmembrane domain of Kir2.1. Significance: These findings provide new insights into the mechanisms underlying lipid regulation of ion channels.
No takes yet. Share an insight, caveat, or question.
Rosenhouse‐Dantsker et al. (2013) studied this question. Cholesterol was evaluated on Cholesterol binding regions in Kir2.1. A combined computational-experimental approach identified two putative cholesterol-binding regions in the transmembrane domain of Kir2.1, suggesting a novel cholesterol binding motif.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: